Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2018-02-19 Regulatory Filings
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Transactions under Novozymes’ stock buyback program
Regulatory Filings
2018-02-19 English
Transactions under Novozymes’ stock buyback program
Transaction in Own Shares Classification · 100% confidence The document is a short announcement regarding transactions within a share buyback program ('aktietilbagekøbsprogram'). It directs the reader to an attached file for the full details. According to the 'Menu vs Meal' rule, since this is a short announcement of a transaction rather than the full report itself, and it specifically concerns the company buying back its own shares, it is classified as a Transaction in Own Shares (POS).
2018-02-19 Danish
Transaction in Own Shares 2018
Transaction in Own Shares Classification · 100% confidence The document text is extremely short (638 characters) and explicitly states 'Initiation of stock buyback program' and directs the reader to 'Please read the full announcement in the attached PDF' with a link. This structure—a brief announcement pointing to a full document—matches the criteria for a Report Publication Announcement (RPA) or, given the specific subject matter, a Transaction in Own Shares (POS). Since the subject is explicitly a stock buyback program, the most specific classification is 'Transaction in Own Shares' (POS). However, following the 'MENU VS MEAL' rule, if this is just the announcement wrapper, RPA might be considered. Given the direct subject matter (buyback), POS is the most accurate content classification, even if the wrapper is short. A stock buyback is a form of share transaction.
2018-02-13 English
Transaction in Own Shares 2018
Transaction in Own Shares Classification · 99% confidence The document is titled "Påbegyndelse af aktietilbagekøbsprogram" (Commencement of Share Buyback Program) and details the company's plan to repurchase its own B-shares up to a total value of DKK 2 billion during 2018. It discusses the use of repurchased shares to reduce share capital and fulfill obligations related to incentive programs. This activity directly corresponds to the definition of a company buying back or selling its own shares. Therefore, the appropriate filing type is 'Transaction in Own Shares' (POS).
2018-02-13 English
Initiation of stock buyback program
Transaction in Own Shares Classification · 95% confidence The document is a short announcement titled 'Påbegyndelse af aktietilbagekøbsprogram' (Commencement of share buyback program) which directs the reader to a link for the full details. Per the 'Menu vs Meal' rule, since this is a short announcement regarding the initiation of a share repurchase program rather than the detailed transaction report itself, it is classified as a Report Publication Announcement.
2018-02-13 Danish
Initiation of stock buyback program
Transaction in Own Shares Classification · 100% confidence The document is an official announcement regarding the initiation of a stock buyback program by Novozymes. It details the total value of shares to be repurchased, the purpose of the buyback (reducing common stock and meeting incentive obligations), and the regulatory framework (EU Market Abuse Regulation) under which the program will operate. This falls directly under the definition of a company buying back its own shares.
2018-02-13 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.